JBM (Healthcare) Limited (SEHK: 2161)
Health Care · Pharmaceuticals · HK
HK$1.89
-0.79% today · -38.4% 1Y
JBM (Healthcare) Limited (SEHK: 2161) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $197.67M and employs 404 people.
Over the last twelve months the share price has lost 38.4%, trading between 1.82 and 3.15.
Tweenvest scores JBM (Healthcare) Limited across four factors: quality 69/100, value 66/100, growth 85/100, dividend 90/100. Its strongest factor is dividend.
2161 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $197.67M
- Revenue (TTM)
- $106.46M
- P/E
- 7.67
- EPS
- 0.25
- Dividend yield
- 8.98%
- Beta (5Y)
- 0.19
- 52-week high
- HK$3.15
- 52-week low
- HK$1.82
- Avg volume (3M)
- —
- Shares outstanding
- 819.80M
- Employees
- 404
- Next earnings
- —
About JBM (Healthcare) Limited
JBM (Healthcare) Limited functions as an investment holding company that operates across Asia, engaging in the entire process of bringing healthcare and wellness products to market, from their conception and production to their promotion, distribution, and ultimate sale. The firm's offerings include a diverse range of consumer health products, such as its own branded traditional Chinese medicines – spanning everything from over-the-counter medications to specific medicated and non-medicated treatments. Additionally, it supplies diagnostic equipment and various pharmaceutical goods. Beyond manufacturing, JBM (Healthcare) is also involved in the buying, selling, and reselling (wholesale and retail) of Chinese medicines. Its business activities extend to the trade of medical supplies and pharmaceuticals, as well as the sale of general health and herbal products. Established in 2020, the company's main operations are directed from its headquarters in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary entity of JBM Group (BVI) Limited.
- ISIN
- KYG1090B1077
- Founded
- 2020
- Listed since
- Feb 5, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.90 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.03 | -1.14% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.57 | -1.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.79% |
Figures last refreshed Aug 18, 2026.